Le Lézard

News by subject: Conference

1 2 3 4 5 6 7 8 9 10

Today

18:00
On Thursday, June 2, 2022, at 3:30pm ET / 12.30pm PT Rivian's founder and CEO RJ Scaringe will participate in Bernstein's 38th Annual Strategic Decisions Conference. A live webcast of the fireside chat will be available here. About Rivian: Rivian...

16:10
Ulta Beauty, Inc. today announced that Dave Kimbell, chief executive officer, Scott Settersten, chief financial officer, and Kecia Steelman, chief operating officer, will participate in a Fireside Chat at the Baird 2022 Global Consumer, Technology &...

16:10
Ambrx Biopharma Inc., or Ambrx, , a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision Biologics (EPBs), today announced that Feng Tian, Ph.D., Chairman of the Board, President...

16:05
Analog Devices, Inc. today announced that the Company's Chief Executive Officer and Chair, Vincent Roche, will speak at the Bernstein 38th Annual Strategic Decisions Conference in New York, NY on Wednesday, June 1, 2022, at 10:00 a.m. Eastern time....

15:55
Hess Corporation announced today that John Hess, Chief Executive Officer, will participate in a fireside chat at Bernstein's 38th Annual Strategic Decisions Conference on Thursday, June 2, 2022, at 10:00 a.m. Eastern Time. A live audio webcast and...

13:50
Cyngn (or the "Company") , a developer of innovative autonomous driving software solutions for industrial and commercial applications, today announced its collaboration with Qualcomm Technologies, Inc. to demonstrate autonomous mobile robots (AMRs)...

12:45
City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced it would present research on promising treatments for bladder and blood cancers, as well as studies on precision medicine and an...

12:05
Members of the Messaging, Malware and Mobile Anti-Abuse Working Group (M3AAWG) will gather June 13-16, 2022 in London as part of its global collaboration on messaging and online abuse. At its 55th general meeting, members and invited experts will...

10:15
The IoT CommunityTM (Internet of Things Community), the world's largest community of CXOs and IoT professionals and practitioners, announces Synadia - The connective fabric for modern distributed systems has joined its elite IoT ecosystem as a...

09:05
LintonPharm Co., Ltd., a China-based biopharmaceutical company focusing on the development of T cell engaging bispecific antibodies for cancer immunotherapy, announces that preliminary results of Catumaxomab for advanced Gastric Cancer (GC) with...

09:05
U.S. Bancorp announced today that Chairman, President and CEO Andy Cecere and Vice Chair and Chief Financial Officer Terry Dolan will present at the Bernstein Annual Strategic Decisions Conference in New York. The presentation will begin at 10 a.m....

09:05
System1, Inc. ("System1" or the "Company"), an omnichannel customer acquisition marketing platform, announced that the Company will be participating in the BofA Securities Global Technology Conference to be held at The Ritz-Carlton Hotel, San...

09:05
QuidelOrtho Corporation ("QuidelOrtho") announced completion of the transaction combining Quidel Corporation ("Quidel") and Ortho Clinical Diagnostics Holdings plc ("Ortho"), creating QuidelOrtho, a leading in vitro diagnostics company. The new...

08:35
Zoetis Inc. will participate in the Stifel 2022 Jaws and Paws Conference on Wednesday, June 1, 2022. Glenn David, Executive Vice President and Group President, International Operations, Aquaculture, BioDevices and Pet Insurance, will represent the...

08:35
VistaGen Therapeutics, Inc. , a late clinical-stage, central nervous system (CNS)-focused biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other CNS disorders, today announced...

08:30
Catalent, the global leader in enabling biopharma, cell, gene, and consumer health partners to optimize development, launch, and supply of better patient treatments across multiple modalities, today announced that members of its executive leadership...

08:05
National Vision Holdings, Inc. today announced the Company is scheduled to present at the 42nd Annual William Blair Growth Stock Conference on Wednesday, June 8, 2022 at 8:40 a.m. Central Time. A live webcast of the presentation can be accessed on...

08:05
Mercy BioAnalytics, Inc., a pioneer in extracellular vesicle-based liquid biopsies for the early detection of cancer, today announced that the Mercy Halo Ovarian Cancer (OC) assay substantially outperformed CA125 when distinguishing patients with...

08:05
Zuora, Inc. , the leading cloud-based subscription management platform provider, today announced that it will participate in the 19th Annual Craig-Hallum Institutional Investor Conference on Wednesday, June 1, 2022. Zuora Chief Financial Officer Todd...

08:05
The ONE Group Hospitality, Inc. ("The ONE Group" or the "Company") today announced that the Company will participate in five upcoming investor conferences: The Company will host virtual investor meetings at the Loop Capital Markets 2022 Investor...

08:05
Starry Group Holdings, Inc. (the "Company" or "Starry"), a licensed fixed wireless technology developer and internet service provider, today announced its Chief Executive Officer, Chet Kanojia, will participate in a fireside conversation and...

08:05
Ford Chief Financial Officer John Lawler will provide an update on the company's Ford+ plan for growth and value creation during a fireside chat with auto analyst Emmanuel Rosner at the Deutsche Bank 2022 Global Automotive Conference. The conference...

08:05
Zuora, Inc. , the leading cloud-based subscription management platform provider, today announced that its Chief Financial Officer, Todd McElhatton, will participate in a fireside chat during the Jefferies Software Conference on Thursday, June 2, 2022...

07:50
The Marcus Corporation today announced that company executives will participate in three upcoming investor conferences in June 2022. 14th Annual Gabelli Funds Entertainment & Broadcasting Symposium Gregory S. Marcus, president and chief executive...

07:40
FEELM, the flagship atomization tech brand belonging to SMOORE, today showcased the world's first ceramic coil disposable pod solution series, FEELM Max at Vaper Expo UK 2022 in Birmingham, UK. By launching the solution and showcasing its...

07:30
Power Integrations today announced webcasts of appearances by company executives at the following investor conferences: Cowen Technology, Media & Telecom Conference ? June 2, 2022, at 2:10 p.m. ET Stifel Cross-Sector Insight Conference ? June 7,...

05:35
Zymeworks Inc. , a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, today announced that management will participate in an upcoming investor conference: Jefferies Healthcare Conference. Zymeworks...

03:05
TYAN®, an industry-leading server platform design manufacturer and MiTAC Computing Technology Corporation subsidiary, will exhibit its latest HPC platforms powered by 3rd Gen AMD EPYCtm Processors with AMD 3D V-Cachetm technology for data centers...

03:05
Mavenir, the Network Software Provider building the future of networks with cloud-native software that runs on any cloud and transforms the way the world connects, today announced to have won the SCF Small Cell Awards 2022 for Outstanding...

02:05
Regulatory News: Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that an abstract reporting preliminary data from the two Phase I trials assessing...

02:05
iOnctura SA, a clinical-stage oncology company targeting key resistance mechanisms in solid tumours, will present at the 2022 ASCO (American Society of Clinical Oncology) Annual Meeting, taking place June 3-7 in Chicago, new interim Phase I data from...


26 may 2022

17:35
Flatiron Health today announced three Flatiron-authored abstracts have been accepted for poster discussion and presentations at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held June 3-7. "As demonstrated by our...

17:35
Alpine Immune Sciences, Inc. , a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune and inflammatory diseases, today announced the acceptance of abstracts for presentation at the 2022...

17:35
4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, today announced the presentation of a trial in progress poster from...

17:30
Takeda Pharmaceutical Company Limited (TSE:4502) and Seagen Inc., today announced that overall survival (OS) data from the Phase 3 ECHELON-1 clinical trial of an ADCETRIS® (brentuximab vedotin) plus chemotherapy combination will be presented in an...

17:30
Aura Biosciences Inc. , a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced the publication of preclinical data on AU-011, its first VDC...

17:25
Crane Holdings, Co. , a diversified manufacturer of highly engineered industrial products, provided an update on certain previously announced transactions, adjusted its full-year 2022 earnings guidance, and provided details about an upcoming investor...

17:25
Cadence Design Systems, Inc. : WHO: John Wall, senior vice president and chief financial officer, and Richard Gu, vice president, investor relations, Cadence Design Systems, Inc. . WHAT: Wall and Gu will participate in a virtual fireside chat at...

17:15
Veracyte, Inc. today announced that new data from a large, population-based study reinforce the clinical utility of the Decipher Prostate genomic classifier. The findings, which will be shared for the first time at the 2022 American Society of...

17:10
Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics, today shared a Trials in Progress poster that is being presented at the American Society of...

17:10
Spectrum Pharmaceuticals , a biopharmaceutical company focused on novel and targeted oncology therapies, today announced additional exploratory data for poziotinib in non-small cell lung cancer (NSCLC) patients harboring HER2 exon 20 insertion...

17:10
Foundation Medicine, Inc., a pioneer in molecular profiling for cancer, today announced that the company and its collaborators will present a total of 26 abstracts at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting held virtually...

17:10
Veracyte, Inc. announced today new data from a clinical research study demonstrating the ability of its Immunoscore Immune Checkpoint (IC) assay to predict which patients with metastatic non-small cell lung cancer (NSCLC) may benefit from immune...

17:10
Puma Biotechnology, Inc. , a biopharmaceutical company, announced the publication of two abstracts on neratinib to be presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting. The ASCO Annual Meeting will be held in person at...

17:05
Inspirna, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule and biologic cancer therapeutics, announced today new data from the ongoing Phase 1b clinical trial studying RGX-202-01 in combination with FOLFIRI...

17:05
Zymeworks Inc. , a clinical-stage biopharmaceutical company developing next-generation multifunctional biotherapeutics, today announced new clinical data for the HER2?targeted bispecific antibody zanidatamab in both HER2-positive breast cancer and...

17:05
Exelixis, Inc. today announced results from a phase 2, investigator-sponsored trial of cabozantinib (CABOMETYX®) in combination with pembrolizumab in patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). The data will...

17:05
ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced additional efficacy data from the pivotal SORAYA study evaluating mirvetuximab soravtansine (mirvetuximab) monotherapy...

17:05
Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today announced encouraging data to be presented for the multi-targeted tyrosine kinase inhibitor (TKI), Cabometyx® (cabozantinib), across a range of cancer types at this year's American Society of...

17:05
MEI Pharma, Inc. , a late-stage pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty pharmaceutical company creating innovative medical solutions utilizing the...

1 2 3 4 5 6 7 8 9 10